Pioneering Research at KAIST Unveils Innovative Approach to Cancer Treatment

Despite the plethora of advancements in cancer treatment technologies, their fundamental aim remains the eradication of cancer cells. This approach faces intrinsic limitations, including drug resistance, relapse, and severe side effects resulting from damage to healthy cells.

A research team at the Korea Advanced Institute of Science and Technology (KAIST) has developed an innovative technique for treating colon cancer. This method does not aim to kill cancer cells but rather to transform them into a state resembling normal colon cells, thereby avoiding adverse effects.

The team observed the regression pathway of cancer cells during tumorigenesis and, based on this insight, devised a technology to construct a gene network numerical model relevant to the differentiation trajectory of normal cells. Through simulation analysis, they systematically identified key molecular switches that induce normal cell differentiation. When these molecular switches act on colon cancer cells, the cancer cells revert to a normal state. This outcome has been validated through molecular, cellular experiments, and animal studies.

This research pioneers a novel approach to cancer cell reversion through systematic analysis, moving beyond serendipitous discoveries. This breakthrough brings hope for reversible treatments across various cancer types and introduces a fresh concept in cancer therapy: achieving systematic reversion of cancer cells through gene network analysis.